Moderna (MRNA) Capital Expenditures (2018 - 2026)
Moderna (MRNA) posted quarterly Capital Expenditures of $37.0 million for Q2 2026, up 1133.33% year-over-year from $3.0 million in Q2 2025, and down 40.32% on a QoQ basis from $62.0 million in Q1 2026.
Moderna (MRNA) Capital Expenditures (2018 - 2026) Analysis & Trends
Moderna has reported Capital Expenditures for 9 years, with the latest figure at $37.0 million in Q2 2026.
- Capital Expenditures for Q2 2026 came in at $37.0 million, up 1133.33% year-over-year; the trailing twelve-month figure through Jun 2026 was $171.0 million (down 78.44% YoY), and the FY2025 annual result was $192.0 million, down 81.73% from the prior year.
- Capital Expenditures fell to $37.0 million in Q2 2026, from $62.0 million in the prior quarter.
- Over five years, Capital Expenditures peaked at $522.0 million in Q4 2024 and troughed at $3.0 million in Q2 2025.
- A 5-year average of $136.1 million and a median of $115.0 million in 2023 frame the typical range for Capital Expenditures.
- The widest annual swing landed in 2025, when Capital Expenditures sank 98.35%; it then jumped 1133.33% in 2026.
- A 5-year view of Capital Expenditures shows it stood at $92.0 million in 2022, then surged by 139.13% to $220.0 million in 2023, then surged by 137.27% to $522.0 million in 2024, then sank by 92.53% to $39.0 million in 2025, then dropped by 5.13% to $37.0 million in 2026.
- Per Business Quant data, the three most recent Capital Expenditures figures were $37.0 million in Q2 2026, $62.0 million in Q1 2026, and $39.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.29 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.02 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 572,662.23 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 251.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 34.68 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Moderna | 25.26 Bn | 20.13 Bn | 52.00 Mn | 37.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 37.00 Mn |
| Jun 30, 2026 | 37.00 Mn |
| Mar 31, 2026 | 35.00 Mn |
| Mar 31, 2026 | 35.00 Mn |
| Dec 31, 2025 | 39.00 Mn |
| Dec 31, 2025 | 39.00 Mn |
| Sep 30, 2025 | 106.00 Mn |
| Sep 30, 2025 | 106.00 Mn |
| Jun 30, 2025 | -70.00 Mn |
| Jun 30, 2025 | -70.00 Mn |
| Mar 31, 2025 | 117.00 Mn |
| Mar 31, 2025 | 117.00 Mn |
| Dec 31, 2024 | 19.00 Mn |
| Dec 31, 2024 | 19.00 Mn |
| Sep 30, 2024 | -300.00 Mn |
| Sep 30, 2024 | -300.00 Mn |
| Jun 30, 2024 | 182.00 Mn |
| Jun 30, 2024 | 182.00 Mn |
| Mar 31, 2024 | 196.00 Mn |
| Mar 31, 2024 | 196.00 Mn |